Article Text

Food and beverage industry interference in science and policy: efforts to block soda tax implementation in Mexico and prevent international diffusion
  1. Andrea Pedroza-Tobias1,
  2. Eric Crosbie2,3,
  3. Melissa Mialon4,
  4. Angela Carriedo5,
  5. Laura A Schmidt6,7
  1. 1Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, USA
  2. 2School of Community Health Sciences, University of Nevada, Reno, Nevada, USA
  3. 3Ozmen Institute for Global Studies, University of Nevada, Reno, Nevada, USA
  4. 4Trinity Business School, Trinity College Dublin, Dublin, Ireland
  5. 5World Public Health Nutrition Association, London, UK
  6. 6Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, USA
  7. 7Department of Humanities and Social Sciences, University of California San Francisco, San Francisco, California, USA
  1. Correspondence to Dr Laura A Schmidt; Laura.Schmidt{at}ucsf.edu

Abstract

Mexico is the largest soft drink market in the world, with high rates of obesity and type 2 diabetes. Due to strains on the nation’s productivity and healthcare spending, Mexican lawmakers implemented one of the world’s first public health taxes on sugar-sweetened beverages (SSBs) in 2014. Because Mexico’s tax was designed to reduce SSB consumption, it faced strong opposition from transnational food and beverage corporations. We analysed previously secret internal industry documents from major corporations in the University of California San Francisco’s Food Industry Documents Archive that shed light on the industry response to the Mexican soda tax. We also reviewed all available studies of the Mexican soda tax’s effectiveness, contrasting the results of industry-funded and non-industry-funded studies. We found that food and beverage industry trade organisations and front groups paid scientists to produce research suggesting that the tax failed to achieve health benefits while harming the economy. These results were disseminated before non-industry-funded studies could be finalized in peer review. Mexico still provided a real-world context for the first independent peer-reviewed studies documenting the effectiveness of soda taxation—studies that were ultimately promoted by the global health community. We conclude that the case of the Mexican soda tax shows that industry resistance can persist well after new policies have become law as vested interests seek to roll back legislation, and to stall or prevent policy diffusion. It also underscores the decisive role that conflict-of-interest-free, peer-reviewed research can play in implementing health policy innovations.

  • diabetes
  • health policy
  • nutrition
  • public health

Data availability statement

Data are available in a public, open access repository.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available in a public, open access repository.

View Full Text

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Handling editor Seye Abimbola

  • Twitter @apedroz9, @MIALONMelissa, @acarriedo

  • Contributors All authors contributed to data collection, analysis, interpretation and revision for important intellectual content. LS, EC and AP-T drafted the manuscript.

  • Funding The work was supported by Bloomberg Philanthropies. AP-T has a scholarship from the Mexican National Council of Science and Technology (CONACyT377279). The funders had no role in design, conduct, collection, management, analysis and interpretation of the data or in the preparation, review or approval of the manuscript.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.